Guy Rosenthal is a seasoned executive in the biotech, pharmaceutical, and healthcare sectors, currently serving as President and CEO of Oryn Therapeutics. They have held notable advisory roles with organizations such as Seed Health and PrecisionMedicine4Me, and previously worked as a Business Development Officer at UCLA Technology Development Group. Guy earned a Doctor of Philosophy in Biochemistry and Molecular Biology from Bar-Ilan University and an MBA from UCLA Anderson School of Management, among other academic achievements. Additionally, they serve on various advisory boards, including ProFuse Technology and Nucleate, while also leading The French Horn Fund as Chairman.
This person is not in the org chart
This person is not in any teams
This person is not in any offices